Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Leukemia Research|January 1, 1991
Prognostic implication and characterization of the blast cell population in the myelodysplastic syndromeJ E Goasguen, J M Bennett, C Cox, et al.
Clinical and Experimental Dermatology|February 21, 2006
Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutisK M T Watson, G Mufti, J R Salisbury, et al.
Bone Marrow Transplantation|November 30, 2004
Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantationK Raj, S Narayanan, B Augustson, et al.
Gene Therapy|February 24, 1998
In vitro immune modulation by antibodies coupled to tumour cellsD Darling, J Galea-Lauri, J Gäken, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Non-myeloablative stem cell transplantation for congenital immunodeficienciesH B Gaspar, P Amrolia, A Hassan, et al.
Blood|August 15, 2000
Nonmyeloablative stem cell transplantation for congenital immunodeficienciesP Amrolia, H B Gaspar, A Hassan, et al.
Bone Marrow Transplantation|October 14, 2014
A multicentre UK study of GVHD following DLI: rates of GVHD are high but mortality from GVHD is infrequentJ J Scarisbrick, F L Dignan, S Tulpule, et al.
Blood|March 15, 1997
International scoring system for evaluating prognosis in myelodysplastic syndromesP Greenberg, C Cox, M M LeBeau, et al.
Journal of Internal Medicine|October 30, 2018
Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysisJ Canaani, E Beohou, M Labopin, et al.
Blood|October 1, 1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML GroupE Wattel, A Guerci, B Hecquet, et al.
Pageof 3